Brenntag/€BNR
1D1W1MYTD1Y5YMAX
Capital at risk
About Brenntag
Brenntag SE is a global leader in chemical distribution, providing comprehensive solutions in the chemical sector to a diverse range of industries, including pharmaceuticals, personal care, and coatings. Founded in 1874 and headquartered in Essen, Germany, the company operates an extensive network delivering both industrial and specialty chemicals worldwide. Brenntag is listed on the Frankfurt Stock Exchange under the ticker symbol 'BNR', reflecting its significant role in the global market as a connector between chemical manufacturers and an array of industry consumers.
- Ticker
- €BNR
- Sector
- Industrials
- Primary listing
- XETRA
- Employees
- 16,942
- Headquarters
- Essen, Germany
- Website
- www.brenntag.com
Brenntag Metrics
BasicAdvanced
€8.5B
23.47
€2.52
0.53
€1.90
3.21%
Price and volume
Market cap
€8.5B
Beta
0.53
52-week high
€66.74
52-week low
€44.44
Average daily volume
233K
Dividend rate
€1.90
Financial strength
Current ratio
1.703
Quick ratio
1.173
Long term debt to equity
0.732
Total debt to equity
0.807
Dividend payout ratio (TTM)
75.21%
Interest coverage (TTM)
5.82%
Profitability
EBITDA (TTM)
1,047.5
Gross margin (TTM)
25.96%
Net profit margin (TTM)
2.41%
Operating margin (TTM)
5.89%
Effective tax rate (TTM)
39.99%
Revenue per employee (TTM)
€890,000
Management effectiveness
Return on assets (TTM)
4.96%
Return on equity (TTM)
8.53%
Valuation
Price to earnings (TTM)
23.474
Price to revenue (TTM)
0.563
Price to book
1.93
Price to tangible book (TTM)
15.15
Price to free cash flow (TTM)
16.648
Free cash flow yield (TTM)
6.01%
Free cash flow per share (TTM)
3.551
Dividend yield (TTM)
3.21%
Forward dividend yield
3.21%
Growth
Revenue change (TTM)
-5.28%
Earnings per share change (TTM)
-14.07%
3-year revenue growth (CAGR)
-6.63%
10-year revenue growth (CAGR)
3.91%
3-year earnings per share growth (CAGR)
-19.82%
10-year earnings per share growth (CAGR)
1.55%
3-year dividend per share growth (CAGR)
-1.70%
10-year dividend per share growth (CAGR)
6.63%
What the Analysts think about Brenntag
Analyst ratings (Buy, Hold, Sell) for Brenntag stock.
Analyst projections of the future price of Brenntag stock.
Bulls say / Bears say
Q2 2026 showed strong operating momentum: sales increased 11%, operating EBITDA rose 41% to EUR 463 million, gross margin expanded to 26.9%, and full-year EBITDA guidance was raised to EUR 1.35–1.45 billion. (Brenntag)
The cost-out and simplification program is beginning to add operating leverage, generating EUR 41 million of Q2 savings; Brenntag remains on track for EUR 200–250 million of additional savings by 2027 versus the 2025 baseline. (Brenntag)
Brenntag is expanding its higher-value specialty-ingredients platform through the planned acquisition of South Korea’s Woojin Trading, strengthening its beauty and personal-care presence in an attractive market. (Brenntag)
Q1 2026 exposed continued weak underlying demand: sales fell 5.1% on an FX-adjusted basis and operating EBITDA declined 8.3% year over year, with Essentials particularly weak. (Brenntag)
Cash conversion deteriorated sharply in Q2: free cash flow was only EUR 4 million versus EUR 154 million a year earlier, while net financial liabilities rose to EUR 3.1 billion from EUR 2.5 billion at year-end 2025. (Brenntag)
The 2025 dividend was cut approximately 10% to EUR 1.90 per share, while management continues to cite muted demand, geopolitical uncertainty and pricing pressure—signs that shareholder returns remain exposed to a difficult operating environment. (Brenntag)
Data summarised monthly by Lightyear AI. Last updated on 10 Sept 2026.
Brenntag Financial Performance
Revenues and expenses
Brenntag Earnings Performance
Company profitability
Upcoming events
No upcoming events
Funds containing Brenntag
AllEURGBPUSD
Fund name | Fund size | €BNR weighting |
|---|---|---|
iShares STOXX Europe 600 Chemicals€EXV7 | €104M | 3.23% |
iShares DivDAX€EXSB | €562M | 1.23% |
iShares EURO STOXX Mid€DJMC | €572M | 0.84% |
iShares EURO STOXX Mid Cap£DJMC | £491M | 0.84% |
iShares STOXX Europe Mid 200€EXSD | €610M | 0.42% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.